about
A novel role for relaxin-2 in the pathogenesis of primary varicosisIn vivo imaging of extracellular matrix remodeling by tumor-associated fibroblasts.Risk factors for eosinophilic esophagitis.Relaxin abrogates renal interstitial fibrosis by regulating macrophage polarization via inhibition of Toll-like receptor 4 signaling.Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.Relaxin: review of biology and potential role in treating heart failure.Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS.Controlled extracellular matrix degradation in breast cancer tumors improves therapy by trastuzumabRelaxin does not improve Angiotensin II-induced target-organ damage.Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease.Toward a stem cell gene therapy for breast cancer.Serelaxin : a potential new drug for the treatment of acute heart failure.Serelaxin in clinical development: past, present and future.Serelaxin for the treatment of heart failure.In search of a small molecule agonist of the relaxin receptor RXFP1 for the treatment of liver fibrosis.Adenovirus-relaxin gene therapy for keloids: implication for reversing pathological fibrosis.Relaxin signalling in primary cultures of human myometrial cells.Presence of relaxin-2, oxytocin and their receptors in uterosacral ligaments of pre-menopausal patients with and without pelvic organ prolapse.Intranasally administered serelaxin abrogates airway remodelling and attenuates airway hyperresponsiveness in allergic airways disease.Gene duplication and positive selection explains unusual physiological roles of the relaxin gene in the European rabbit.Protection from Cigarette Smoke-Induced Lung Dysfunction and Damage by H2 Relaxin (Serelaxin).Effects of relaxin on relapse and periodontal tissue remodeling after experimental tooth movement in rats.Relaxin: reproductive safeguard turned cardiac?
P2860
Q28728156-A32C5B77-E47A-44AA-B35A-6804AB55B668Q30494704-F7CC86DD-D407-42E8-9DCD-3DDF81B265EAQ31170219-60262BFF-B465-4036-BD1B-EAC7CA61810AQ33591435-310B0796-274C-4737-9703-C3CB5E2637E4Q33623465-59AE392A-47A8-4F59-88C7-A79AED4D0D8CQ33873275-00D14349-62A3-4204-B061-714054055098Q34398874-BBB22CD2-6041-4464-A5B3-21271171BC09Q34621713-4C9F7AE1-0F29-4034-AD15-6B2699271247Q35141812-EC1AF6EF-66D4-4E7F-B355-C7E51E6D70B1Q35970597-4167C7FE-FBAF-49F8-A004-A00995601B71Q37013037-143E038C-03F4-421D-B0FA-B0AF8A72FBC2Q37147122-2C271C8C-2057-4B82-8EBD-5933DF254723Q37209024-6EB55FBE-6360-435C-9818-1E9C227C6781Q38215304-4331439B-0B6F-4AE6-B924-C41A947895EEQ38778886-242379D9-1FEF-421E-84BA-96F68D3DFC47Q38798476-12FB9E4E-FB32-4DFB-A422-51D8B66A9764Q41537671-4C1BEAAD-6738-4F4F-AC19-6F43859968EAQ45870472-15F50550-BFCB-47AD-ABF3-33C0C6E72DA5Q46355454-5586699E-0B5E-4AB8-8474-CAE5A4D62D0AQ50654047-A7B257F6-3D7C-4310-A06C-29A4115AF6AFQ51121563-121D4304-AB9F-4131-9D4A-C10375F35B7DQ51418822-272EE787-CCB1-4E4D-9F6F-6020FC64D196Q51534835-BF74E90A-21BE-4FA2-BE70-371F86C6F700Q54335516-DACCF5FE-C67C-44C6-83E9-C4FA3688605EQ54389934-3CFFD28A-7CD5-450E-B64B-B5D197E1AADE
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Drugs of the future: the hormone relaxin.
@ast
Drugs of the future: the hormone relaxin.
@en
type
label
Drugs of the future: the hormone relaxin.
@ast
Drugs of the future: the hormone relaxin.
@en
prefLabel
Drugs of the future: the hormone relaxin.
@ast
Drugs of the future: the hormone relaxin.
@en
P2093
P1476
Drugs of the future: the hormone relaxin.
@en
P2093
C S Samuel
E N Unemori
M L-K Tang
T D Hewitson
P2888
P304
P356
10.1007/S00018-007-6543-Y
P577
2007-06-01T00:00:00Z